Off-the-Shelf NK Cells in European AML Clinical Trial
Time: 3:30 pm
day: Day One
Details:
- Phase I/II a clinical trial in AML ongoing in the EU
- First outcomes at low doses
- Upcoming geographical and indication expansion
January 30 - February 30
London
